MEDVi, a U.S.-based online weight-loss medication company, has generated $401 million in revenue within a year, operating with only two employees. The company specializes in compounded GLP-1 medications, attracting 250,000 customers by offering a first-month supply at $179, significantly undercutting branded drug prices. MEDVi's success is attributed to extensive outsourcing of medical infrastructure and full-stack AI integration, utilizing tools like ChatGPT for coding, Midjourney for ads, and ElevenLabs for voice processing. This approach has resulted in a net profit margin of 16.2%, far exceeding industry averages. The company's business model leverages API-driven medical capabilities and replaces human labor with AI across various functions, including product development and customer service. MEDVi's strategy of extreme outsourcing and AI utilization has allowed it to operate efficiently without in-house doctors or pharmacies, setting a new standard for enterprise scalability. Despite its rapid growth, MEDVi has not raised any external funding, highlighting the potential of AI-native business models to disrupt traditional industries.